| Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps (NCT05080673) | NRG Oncology | 2022-02-09 |
| MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab (NCT04554836) | TheraOp | 2020-12-29 |
| Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation (NCT04668872) | Memorial Sloan Kettering Cancer Center | 2020-12-07 |
| Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma (NCT03871959) | Centre Leon Berard | 2019-09-15 |
| Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery (NCT04005118) | Assistance Publique - Hôpitaux de Paris | 2019-05-28 |
| Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits (NCT03303547) | Imperial College London | 2017-10-16 |
| Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer? (NCT02945566) | University of Birmingham | 2017-06-14 |
| Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum (NCT02641691) | Washington University School of Medicine | 2016-05-27 |
| Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX (NCT02425683) | US Oncology Research | 2015-03-26 |
| Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer (NCT02046538) | Weill Medical College of Cornell University | 2014-02-01 |
| Midostaurin (PKC412) for Locally Advanced Rectal Cancer (NCT01282502) | Massachusetts General Hospital | 2011-08-01 |
| Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer (NCT01340755) | Massachusetts General Hospital | 2011-03-01 |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer (NCT01294826) | Swedish Medical Center | 2011-02-01 |
| Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01270438) | National Cancer Institute (NCI) | 2010-12-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment (NCT00942266) | Roswell Park Cancer Institute | 2009-07-01 |
| Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer (NCT00707889) | AbbVie (prior sponsor, Abbott) | 2008-10-01 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery (NCT00433576) | National Cancer Institute (NCI) | 2006-12-01 |
| AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer (NCT00397878) | National Cancer Institute (NCI) | 2006-11-01 |
| Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer (NCT00303628) | ECOG-ACRIN Cancer Research Group | 2006-05-11 |
| Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer (NCT00307736) | Massachusetts General Hospital | 2006-05-01 |
| Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer (NCT00100841) | National Cancer Institute (NCI) | 2004-11-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer (NCT00070122) | National Cancer Institute (NCI) | 2004-04-01 |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer (NCT00052585) | National Cancer Institute (NCI) | 2002-10-01 |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00052559) | National Cancer Institute (NCI) | 2002-08-01 |
| Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00026234) | National Cancer Institute (NCI) | 2002-02-01 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00032110) | National Cancer Institute (NCI) | 2002-01-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer (NCT00023933) | National Cancer Institute (NCI) | 2001-10-01 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (NCT00025337) | National Cancer Institute (NCI) | 2001-09-01 |
| Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00006094) | National Cancer Institute (NCI) | 2000-07-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00003799) | National Cancer Institute (NCI) | 1999-05-01 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer (NCT00003873) | National Cancer Institute (NCI) | 1999-04-01 |